Simultaneously, at the mRNA level, chemerin, CCRL2, Flt-1, PlGF, and LDLR showed a tendency for upregulation in preeclampsia explant tissue compared with healthy controls, whereas CMKLR1 and SREBP2 did not (Figure 4B). This evidence concerns the gene RARRES2 and preeclampsia.